Ashland has launched Perfectyl biofunctional (INCI: Chamomilla recutita (matricaria) flower/leaf extract), an organic Oregonian chamomile extract that relaxes facial lines without the intervention of injections.
The material, rich in GABA amino acid (sometimes called "slow Botox") and flower acids, is in line with increased interest in cosmetic procedures and non-invasive alternatives.
Its functionality was reportedly "predicted" by artificial intelligence; per Ashland, Perfectyl acts on the GABA pathway through GABAA expression ex vivo, resulting in the relaxing of facial lines and minimizing post-inflammatory hyperpigmentation and sebum overproduction associated with environmental and lifestyle stressors.
The results can reportedly be achieved across three skin ethnicities and four phototypes, rendering the technology ideal for inclusive beauty solutions offering perfecting and anti-aging claims.
“Recent studies show that GABA is associated with skin pigmentation, remodeling and muscle relaxation,” said Isabelle Imbert, Ph.D., R&D director, Ashland. “GABA amino acid is a neurotransmitter described to be the new natural cosmetic alternative solution to botox as facial line expression relaxer.”
“The younger generation of women are increasingly using non-surgical aesthetic procedures to get flawless skin, and this trend is driven by social media with billions of views,” said Justine Cotton, global marketing, biofunctionals, Ashland. “Inspired by these new aesthetic practices used by Gen Z and millennials to achieve a perfect skin, Ashland has developed Perfectyl to help smooth fine lines, refine enlarged pores, clarify imperfections and uneven skin, specifically pigment spots.”